日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genome-wide identification and expression analysis of RBR-type ubiquitin ligase family genes reveal the role of ZmIBR10 in maize disease resistance

全基因组鉴定和表达分析揭示了RBR型泛素连接酶家族基因中ZmIBR10在玉米抗病性中的作用。

Zhang, Di; Zhou, Fan; Liu, Zezhong; Cao, Hongzhe; Zang, Jinping; Xing, Jihong; Dong, Jingao; Zhang, Kang

Causal associations between abdominal obesity, dietary patterns, and intervertebral disc degeneration: a bidirectional two-sample Mendelian randomization study with clinical validation

腹型肥胖、饮食模式与椎间盘退变之间的因果关系:一项双向双样本孟德尔随机化研究及其临床验证

Wang, YiTing; Pan, JiaoYi; Dai, ZhongHao; Zhao, BaiTong; Mao, XingYong; Ling, GuoYu; Zhang, ZiTong; Liu, ZeZhong; Wang, Xu; Xu, Bing

Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.

利用疫苗接种减轻原始抗原罪,以增强针对 SARS-CoV-2 Omicron 亚型的广谱中和抗体反应

Zhang Guangxu, Wang Qian, Ji Kai, Wang Yuanzhou, Xu Wei, Zhou Jie, Liu Zezhong, Xiu Ruixue, Xing Lixiao, Zhou Jianghao, Shi Yuren, Lu Xishan, Wang Xuanyi, Ying Bo, Lu Lu, Jiang Shibo

Frontiers in combating emerging infectious diseases: An editorial perspective

应对新发传染病的前沿:社论视角

Zhu, Yun; Liu, Zezhong; Jiang, Shibo

Antisera and antivirals targeting the conserved domains in SARS-CoV-2 S2 subunit are effective against ACE2-using MERSr-CoVs with spillover potential

针对SARS-CoV-2 S2亚基保守结构域的抗血清和抗病毒药物对具有溢出潜力的、利用ACE2的MERSr-CoV有效。

Sun, Lujia; Feng, Bianying; Liu, Zezhong; Chen, Jingqi; Hao, Xiangwen; Xia, Shuai; Lu, Lu; Man, Qiuhong; Jiang, Shibo; Wang, Xinling

Receptor-binding domain-associated serotypes of SARS-CoV-2

SARS-CoV-2 受体结合域相关血清型

Liu, Zezhong; Lu, Lu; Jiang, Shibo

Single-cell profiling uncovers synovial fibroblast subpopulations associated with chondrocyte injury in osteoarthritis

单细胞分析揭示了与骨关节炎中软骨细胞损伤相关的滑膜成纤维细胞亚群

Liu, Zezhong; Sun, Yongqi; Pan, Jiaoyi; Guo, Kechun; Tang, Zhi; Wang, Xiaofeng

RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion

撤稿文章:SARS-CoV-2 通过其刺突蛋白介导的膜融合感染 T 淋巴细胞

Wang, Xinling; Xu, Wei; Hu, Gaowei; Xia, Shuai; Sun, Zhiping; Liu, Zezhong; Xie, Youhua; Zhang, Rong; Jiang, Shibo; Lu, Lu

A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates

一种基于SARS-CoV-2原始毒株RBD的泛沙贝病毒疫苗可在非人灵长类动物中诱导产生针对XBB的强效中和抗体

Liu, Zezhong; Zhou, Jie; Wang, Xinling; Xu, Wei; Teng, Zheng; Chen, Hongyou; Chen, Min; Zhang, Guangxu; Wang, Yuanzhou; Huang, Jinghe; Wang, Qian; Jiang, Shibo; Lu, Lu

Application of "B+1" heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines

应用“B+1”异源加强策略预防对广谱冠状病毒疫苗产生耐药性的SARS-CoV-2变异株感染

Liu, Zezhong; Lu, Lu; Jiang, Shibo